93942-91-7

93942-91-7 structure

Name: Acetyl-(Tyr1,D-Arg2)-GRF (1-29) amide
Chemical Name: 1-29-Somatoliberin (human pancreatic islet), N-acetyl-2-D-arginine-29-L-argininamide
CAS Number: 93942-91-7
Molecular Formula: C₁₅₄H₂₅₅N₄₇O₄₃S
Molecular Weight: 3485.027
Catalog: Research Areas Endocrinology
Create Date: 2016-10-20 09:54:52
Modify Date: 2025-08-25 21:58:30
Acetyl-(D-Arg2)-GRF (1-29) amide (human) is an antagonist of growth hormone releasing factor (GRF). Acetyl-(D-Arg2)-GRF (1-29) amide (human) inhibits the release of growth hormone (GH) and can be used for endocrine research[1].

Name	1-29-Somatoliberin (human pancreatic islet), N-acetyl-2-D-arginine-29-L-argininamide
Synonyms	N-Acetyl-L-tyrosyl-D-arginyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucylglycyl-L-glutaminyl-L-leucyl-L-seryl-L-al anyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-methionyl-L-seryl-L-argininamide L-Argininamide, N-acetyl-L-tyrosyl-D-arginyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucylglycyl-L-glutaminyl-L-leu cyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-methionyl-L-seryl- Somatoliberin (human pancreatic islet), N-acetyl-2-D-arginine-29-L-argininamide-30-de-L-glutamine-31-de-L-glutamine-32-deglycine-33-de-L-glutamic acid-34-de-L-serine-35-de-L-asparagine-36-de-L-glutamine-37-de-L-glutamic acid-38-de-L-arginine-39-deglycine-40-de-L-alanine-41-de-L-arginine-42-de-L-alanine-43-de-L-arginine-44-de-L-leucinamide-

Description	Acetyl-(D-Arg2)-GRF (1-29) amide (human) is an antagonist of growth hormone releasing factor (GRF). Acetyl-(D-Arg2)-GRF (1-29) amide (human) inhibits the release of growth hormone (GH) and can be used for endocrine research[1].
Related Catalog	Research Areas >> Endocrinology Signaling Pathways >> Others >> Others
Target	Growth hormone releasing factor, GRF; Growth hormone, GH[1]
References	[1]. Lumpkin MD, et al. Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist. Endocrinology. 1989 Mar;124(3):1522-31.